News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pfizer Japan Inc. Obtains Manufacturing Approval Of Gabapentin For Antiepileptic
August 14, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Pfizer Japan Inc. has obtained manufacturing approval of Gabapentin on July 26. Gabapentin can be taken in conjunction with other drugs. Since it does not induce drug-metabolizing enzymes, it has proven to be safely taken with other drugs.
Twitter
LinkedIn
Facebook
Email
Print
Asia
MORE ON THIS TOPIC
Business
4 CDMOs to consider when outsourcing manufacturing
September 8, 2026
·
5 min read
·
Angela Gabriel
Startups
10 life sciences startups selected for accelerator program
September 4, 2026
·
2 min read
·
Angela Gabriel
Lung cancer
Summit, Akeso’s ivonescimab bests Merck’s Keytruda in China trial—again
September 3, 2026
·
2 min read
·
Annalee Armstrong
Deals
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
September 3, 2026
·
1 min read
·
Tristan Manalac